跳至主要内容
临床试验/CTRI/2024/02/062901
CTRI/2024/02/062901尚未招募2 期

Evaluation of Efficacy and Safety of Roghan-e-Bars in the treatment of Bahaq (Pityriasis versicolor) - A Randomized Standard Controlled Study. - nil

Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1) Patients aged 18 to 60 years of either sex
  • 2) Patients who are willing to participate after signing informed consent.
  • 3) Clinically diagnosed patient of pityriasis versicolor.
  • 4) KOH (potassium hydroxide) positive

排除标准

  • 1 Subjects suffering from other concomitant skin diseases and taking treatment for them.
  • 2 KOH (potassium hydroxide) negative.
  • 3 Immunocompromised conditions like HIV Infection, AIDS and malignancy etc.
  • 4 Patients of Diabetes Mellitus.
  • 5 Any active psychiatric illness.
  • 6 Any systemic diseases that will hamper the patient’s follow up like pulmonary or cardiovascular or hepato renal dysfunction.
  • 7 Pregnant and lactating women.

研究者

发起方
Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital

相似试验